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Abstract 
Trm10 catalyzes N-1 methylation of G9 (m
1
G9) for at least 10 tRNA species in S. 
cerevisiae, including tRNA
Gly
.  However, at least 12 yeast tRNA species, including tRNA
Val
 and 
tRNA
Leu
, have an unmodified G9, and the sequence elements that define tRNA substrates for 
Trm10 are unknown and are not obvious from simple sequence comparison.  To investigate 
Trm10 tRNA substrate specificity, we have developed a sensitive assay using site-specifically 
labeled Gly, Leu and Val tRNAs.  Consistent with the in vivo methylation pattern, tRNA
Leu
 is 
not a Trm10 substrate, yet surprisingly, both tRNA
Gly
 and tRNA
Val
 are substrates for m
1
G9 
modification in vitro.  A comparison of steady-state kinetic parameters for Trm10 activity with 
tRNA
Val
 and tRNA
Gly
 reveals that kcat /KM, an indicator of substrate specificity, is nearly 
identical for both substrates.  Therefore, these data suggest that Trm10 must use additional 
mechanisms to distinguish between some tRNA substrates in vivo.   
 Since the mechanism by which Trm10 methylates tRNA is unknown and there is no 
identifiable sequence homology between Trm10 and other methyltransferases, it is important to 
identify Trm10 residues that participate in catalysis.  We have investigated the role of several 
highly conserved Trm10 residues by mutagenesis of these residues to alanine, revealing at least 8 
amino acids that appear to be important for catalysis, based on significantly decreased 
methylation activity observed for each variant, and at least 2 amino acid residues that appear to 
be important for substrate recognition, based on similar methylation activity of these two variants 
with Gly and Val tRNA substrates.  The identification of these residues is a necessary and 
important first step toward determination of the molecular basis for Trm10 m
1
G9 activity, a 
potentially novel methyltransferase enzymatic mechanism. 
Introduction 
  A tremendous amount of cellular energy is committed towards tRNA processing, editing, 
and modification.  The simple answer for why tRNA maturation and maintenance necessitates 
priority in depletion of cellular energy stores is relatively obvious; tRNAs are essential adaptor 
molecules required for translation of genes into many of the functional and structural units of the 
cell, or proteins.  This biological-worldview convincingly argues that tRNAs are essential 
biological molecules that play a critical role in maintaining life and inherent processes; a Rosetta 
stone of the molecular world which functions to decode mRNA hieroglyphics coordinately with 
the ribosome, into vital protein products.  tRNAs central role in biology is unquestionable, 
however this does not adequately explain the biological significance for the multitude of tRNA 
modifications and biogenesis steps that have hitherto escaped explanation.     
 Among classes of RNA molecules, tRNAs are among the most extensively modified.  
Nearly all tRNA molecules throughout every domain of life contain modified nucleic acids that 
can be methylated, which is also observed on associated ribose sugars, isoprenylated, 
carboxymethylated, dihydrouridylated and psuedouridylated to name a few (1-3).  Moreover 
types, or subsets, of modifications are often conserved at unique positions across the spectrum of 
eukaryotic tRNAs.  Some examples include m
1
G37, which ensures the fidelity of translation by 
prevention of a specific frameshift mutation (4), or m
2
2G in yeast which occurs only at G26 in 
many tRNAs (3).  
The locations of tRNA modifications often provide insight related to their potential 
biological significance and modifications can be characterized into two general categories based 
on this parameter. Essential modifications are often found to occur in or around the anticodon 
and are critical for ensuring the fidelity of translation; m
1
G37 is one example already mentioned 
that occurs next to the anticodon in the anticodon loop.  The anticodon itself usually contains at 
least one if not more modified bases, some of which can be important for wobble pairing (5-8) or 
serve as identity markers for aminoacylation (9).  The other category of tRNA modifications are 
further removed from the anticodon loop/stem.  Notably, many of these have been deemed “non-
essential” due to the fact that single deletion strains of the enzymes that catalyze these 
modifications do not exhibit observable growth defects, however a growing body of evidence 
indicates that these modifications may play important roles in tRNA function, perhaps by 
ensuring the stability of tRNAs or affecting nuclear-cytoplasmic trafficking, since combinations 
of two or more of these deletion mutants result in serious defects in cell growth (10-12).  
The modification investigated in this study is N-1 methylation of guanosine residues 
(Fig.1) unique to position 9 (m
1
G9), particularly with respect to specific tRNAs found in 
Saccharomyces cerevisiae.  The enzyme responsible for m
1
G9 formation is Trm10, a 
methyltransferase that catalyzes the transfer of a methyl group from S-adenosylmethionine 
(SAM) to the N-1 atom of guanosine, resulting in the formation of m
1
G and S-
adenosylhomocysteine (SAHcy) as products. Before this investigation a biochemical genomics 
based approach was used to identify TRM10 as the gene responsible for m
1
G9 activity (13).   A 
library of purified yeast GST-ORF fusion proteins were used to identify the protein responsible 
for tRNA m
1
G9 methyltransferase activity, Trm10, which was subsequently purified to facilitate 
characterization of its enzymatic activity, and subsequently shown to be responsible for all 
known instances of m
1
G9 modification in yeast tRNAs.   Importantly, there is no decrease in cell 
viability resultant from the loss of m
1
G9 as demonstrated by wild-type growth of the deletion 
strain in rich and minimal media and at different temperatures. This result differs from what is 
known about the only other known m
1
G forming enzyme in yeast, Trm5, where trm5∆ strains 
grow extremely slowly (14).  Although trm10∆ yeast show no observable phenotype under 
normal physiological conditions, deletion strains grown in the presence of low concentrations of 
5-Fluorouracil (5-FU) that are not inhibitory to the growth of a wild-type strain display a non-
viable phenotypic response that is exacerbated at elevated temperatures (see Fig.2) (15).  
One puzzling feature of Trm10 methyltransferase activity is that only a subset of S. 
cerevisiae tRNAs that contain a G9 are actually m
1
G
 
modified by Trm10 in vivo (3).  Out of the 
22 yeast tRNAs that contain guanosine residues at position 9, at least 10 tRNAs, including 
tRNA
Gly 
are m
1
G modified, while at least 12 other tRNAs, including tRNA
Val
 and tRNA
Leu
, do 
not contain the m
1
G9 modification in vivo (see Fig.4).  Protein and tRNA elements that confer 
substrate specificity have escaped definition thus far.  Direct sequence comparison between in 
vivo m
1
G9 modified and unmodified tRNAs have failed to reveal sequence determinants for 
substrate specificity.  For example, obvious sequence similarities between unmodified and 
modified tRNAs do not occur near G9, within the acceptor stem, or along any portion of these 
tRNAs.   Nor is there a correlation between tRNA size or type of amino acid (i.e. charged, 
aliphatic, small, acid, base etc…) carried by modified versus unmodified tRNAs.  Therefore, the 
basis for Trm10 recognition of some tRNAs but not others is unknown. 
A parallel puzzling feature is that Trm10 shows no conspicuous sequence homology with 
other tRNA methyltransferases that catalyze similar m
1
G
 
formation activities, such as TrmD in 
bacteria and Trm5 in yeast, which both catalyze m
1
G37 formation in their respective tRNA 
substrates.  Another mystery surrounding Trm10 is that while Trm10 homologs are conserved 
throughout yeast and eukaryotes, multiple isoforms of the TRM10 gene are present in higher 
order eukaryotes such as Mus musculus and Homo sapiens.  A function for any of the multiple 
copies in higher order eukaryotes has not been established, however recent evidence suggests a 
potential biological role for at least one isoform in H. sapiens mitochondria as a component of an 
unusual protein-only form of the tRNA maturation enzyme RNaseP (see Fig. 3) (16).  Therefore, 
not only is the basis for Trm10 substrate recognition unknown, but the molecular basis for 
Trm10 methyltransferase activity is unknown as well.   
Due to the lack of understanding regarding the previously described aspects of tRNA 
substrate recognition and catalytic activity of this unusual methyltransferase, the goals of this 
project were to characterize the biochemical function of Trm10, while attempting to address the 
aforementioned issues.  To investigate the molecular basis for Trm10 m
1
G9 methyltransferase 
activity in S. cerevisiae we have used two general approaches, the first being substrate 
specificity, which was probed using steady-state kinetic characterization with site-specifically 
labeled tRNA substrates, and secondly, since there is no structural information available for 
Trm10, potentially catalytic amino acid residues have been probed using single site alanine 
variants.  
 
 
 
 
 
 
 
Results 
 Saccharomyces cervesiae Trm10 expressed and purified using an E. coli expression 
system.  The investigations of substrate specificity and catalytic activity of S. cerevisiae Trm10 
pursued in this research, in both cases, requires the utilization of in vitro enzymatic assays for 
Trm10 methyltransferase activity.  This approach necessitates the use of purified Trm10 protein, 
and to this end, an inducible expression plasmid containing N-terminally His6-tagged S. 
cerevisiae TRM10 with Amp
r 
marker was transformed into E. coli strain BL21(DE3)pLysS. 
Assessment of the soluble crude extract by SDS-PAGE showed elevated levels of Trm10 
expression relative to other proteins, and purification by IMAC followed by dialysis yielded 
yeast Trm10 that was >90%  pure, as judged by SDS-PAGE analysis.  Purified wild-type Trm10 
was stored at -20 °C and the catalytic activity of the purified enzyme  remained stable for at least 
6 months upon storage.   
 Purified Trm10 catalyzes m
1
G9 formation using in vitro transcribed, 
32
P labeled 
tRNAs.  Based on the observation that Trm10 methylates some, but not all, G residues found at 
position 9 of yeast tRNAs in vivo, the ability of Trm10 to selectively methylate specific tRNA 
substrates was investigated.  To address this fundamental question, three tRNAs with different 
methylation patterns observed in vivo were chosen as substrates for these assays: tRNA
Gly
, which 
contains the m
1
G9 modification in vivo, in addition to tRNA
Leu
 and tRNA
Val
, which contain 
unmodified G9 nucleotides in vivo.  To assess the biological activity of S. cerevisiae Trm10 
purified from E. coli, Trm10 activity was measured using each of these three tRNA substrates, 
which were produced by in vitro transcription in the presence of α-32P GTP, resulting in tRNAs 
that are uniformly radiolabeled at the 5'-phosphate of each G-residue in the tRNA primary 
sequence.  All assays were conducted under standard methyltransferase assay conditions (see 
methods) where, in brief, the tRNAs were reacted with Trm10 and the SAM methyl donor, 
product tRNAs are isolated using PCA (25:24:1 Phenol:Chloroform:Acetic Acid) extraction, 
tRNA reaction products are digested to 5’ monophosphorylated nucleotides with nuclease P1 and 
subsequently resolved by thin-layer chromatography (TLC) to separate p*G substrate and p*m
1
G  
product.   
 Using this assay the maximal expected product formed is limited by the fact that only one 
m
1
G nucleotide is formed out of all the radiolabeled G-residues in the tRNA, and thus the 
maximal percent of product formation can be calculated as 1/n*100%, where n= the total number 
of guanosine residues in each substrate tRNA (Fig.5 B).  This assay showed that tRNA
Gly
 
contains an m
1
G modified residue after reaction with Trm10, in amounts that correlate with the 
predicted maximal yield of modification if a single G residue were modified in this tRNA 
substrate.  However there are several issues with this type of assay with regards to further 
investigation of Trm10 activity.  First, use of a uniformly labeled tRNA substrate does not allow 
for specific determination as to whether this modification occurs specifically at position 9.  
Second, due to the low sensitivity of this method, equivalent product formation appears to be 
present in the reactions with similarly labeled tRNA
Val 
and tRNA
Leu 
(Fig.5 A tRNA
Val
 not 
shown), which could not be reliably distinguished from high levels of background radioactivity 
in individual reactions. These two considerations need to be addressed by a Trm10 assay that has 
improved sensitivity for determining m
1
G modification selective for position 9.  On a similar 
note, steady-state kinetic analysis would not be possible using uniformly labeled tRNA 
substrates, because measurement of initial rates of the reaction would require measurement of 
very low levels of product formation. 
 Use of site-specifically labeled, in vitro transcribed tRNA substrates show Trm10 
catalyzes m
1
G9 formation for tRNA
Gly
 and tRNA
Val
, but not tRNA
Leu
. To address the need 
for measuring methyltransferase activity with greater sensitivity, an assay using site-specifically 
labeled tRNA species was performed.  These tRNA substrates differ from the uniformly labeled 
tRNAs in that only the phosphate at position 9 is labeled, and therefore m
1
G9 formation can be 
specifically observed, and a much broader range of catalytic activity can be measured (up to 
100% m
1
G9 tRNA product conversion). Ten fold titration assays of Trm10 with each site-
specifically labeled Gly, Val, and Leu tRNA substrate, under the same methyltransferase assay 
conditions outlined above, was used to determine Trm10 methyltransferase specific activity in 
vitro (10% m
1
G9 product formation in 2 hours per ug protein; see Fig. 6).  Consistent with what 
is known in vivo, tRNA
Gly 
was a substrate for Trm10 catalyzed m
1
G9 formation, while tRNA
Leu
 
did not contain detectable levels of m
1
G9 after treatment with even the highest concentrations of 
Trm10 achievable in the assay (Fig. 6; Leu data not shown).  However, surprisingly, Trm10 
methyltransferase assays with the site-specifically labeled tRNA
Val 
showed robust formation of 
m
1
G9 in this tRNA (Fig.6), a result that is not consistent with the modification status of tRNA
Val
 
observed in vivo.  Based on specific activity data, quantification of the relative rates of 
methyltransferase activity with the two Trm10 substrates, tRNA
Gly
 and tRNA
Val
, show that 
Trm10 is only ~five-fold more active with tRNA
Gly
 compared to tRNA
Val
 (see Fig. 6, Table 1). 
 Primer extension assay confirms tRNA
Val 
and tRNA
Leu 
contain unmodified G9 
residues in vivo, and that a previously unsequenced species of tRNA
Ala
 contains the m
1
G9 
modification in vivo.  Given the surprising result that the tRNA
Val
 was a substrate for Trm10 
methyltransferase activity in vitro, as demonstrated in the above assay, we decided to explicitly 
investigate whether, contrary to the available sequence data (3), the G9 residue in this tRNA is 
actually modified in vivo.  Although 9 tRNA species had been previously shown as subject to 
Trm10-catalyzed methylation at G9, the modification status of tRNA
Val
 and tRNA
Leu
 had not 
been investigated in those assays.  Therefore, we used a similar reverse transcriptase (RT)-based 
primer extension assay, as was used to determine the modification status at G9 for 9 different 
tRNAs isolated from S. cerevisiae known to contain m
1
G9 in vivo from a previous study (13).  
The identification of m
1
G9 in these previously published assays is based on the observation of a 
specific primer extension block that occurs at G10 if G9 is N-1 methylated, since RT is unable to 
form the proper Watson-Crick base pair at the m
1
G9 modified nucleotide.  To demonstrate that 
Trm10 catalyzed m
1
G9 formation is responsible for a primer extension block, an RT based 
primer extension assay was used to compare tRNAs isolated from WT and trm10∆ yeast (Fig.7).  
In this way, the primer extension block should only be observed in tRNA species isolated from 
wild-type cells, but should not be observed in tRNA species isolated from the trm10∆ mutant 
that does not catalyze m
1
G9 modification.  The previous assays were not able to address the 
modification status at G9 for tRNA
Ala
, which is known to be m
1
G9 modified in vivo, nor was the 
in vivo modification status at G9 looked at for tRNAs used in this study, tRNA
Val
 and tRNA
Leu
.  
Both of these issues are addressed by results in the current study. 
 The RT-based primer extension assays were effectively used to analyze the modification 
status at G9 for WT versus trm10 ∆ harvested tRNAs for 5 different tRNA species: tRNA
Gly
 and 
tRNA
Trp
, characterized in the previous study, in addition to tRNA
Val
, tRNA
Leu,
 and tRNA
Ala
, 
results obtained in this study (Fig. 7).  Consistent with in vivo data, wild-type tRNA
Gly,
 tRNA
Trp
, 
and tRNA
Ala
 all show  primer extension stops at G10  as a result of the presence of m
1
G9 in the 
tRNA, while no primer extension stop is observed for these same 3 tRNAs obtained from trm10∆ 
yeast.  Also consistent with in vivo sequence data (3), tRNA
Leu
 and tRNA
Val
 primers extend 
beyond the G10 primer extension stop to the 5’ terminus of tRNAs harvested from either wild-
type and trm10∆ yeast, thus these tRNAs do not contain m1G9.  With respect to tRNA
Val 
, this 
result not only conflates with what had been predicted for its modification status at G9 in vivo, 
but also requires the intriguing result that in vitro transcribed tRNA
Val
 is a substrate for m
1
G9 
modification by Trm10 despite its lack of modification in yeast.  
 Determination of steady-state kinetic parameters for Trm10 activity with in vitro 
tRNA substrates. While the in vitro specific activity measurements indicate only minor 
differences in the ability of Trm10 to discriminate between tRNA
Gly 
and tRNA
Val
 in vitro, the 
primer extension data indicate that Trm10 must be able to distinguish between tRNA
Gly
 and 
tRNA
Val
 in vivo.  Therefore it is important to quantify the extent to which Trm10 recognizes 
certain tRNA species in vitro, in a way that will provide more information about the possible 
sources for differences in recognition, rather than a simple specific activity measurement.  To 
this end steady-state kinetic analysis was used to determine the parameters kcat, KM, and more 
importantly kcat/KM, which is an indicator of substrate specificity, for the in vitro tRNA 
substrates, tRNA
Gly 
and tRNA
Val
, with wild type Trm10. 
 Linear initial rates were measured under saturating conditions for SAM with varying 
concentration of tRNA substrate, which was in at least five fold excess relative to enzyme 
concentration.  The measurement of linear rates was initially hampered by the observation of 
severe product inhibition, which necessitated taking many time points early in the expected 
reaction curve.  Notably, this type of product inhibition has also been observed for the TrmD 
family of enzymes that also catalyze m
1
G
 
formation, and may indicate some shared mechanistic 
features between these two enzyme families that may emerge as the details of the Trm10 
catalytic mechanism are revealed.  Linear initial velocities, normalized for enzyme 
concentration, were plotted against tRNA substrate concentrations in the range of ~0.2 to 4 times 
KM (Fig.8) and the resulting data were fit to the Michaelis-Menten equation to yield the kinetic 
parameters kcat, KM and kcat/KM.   The Trm10 steady-state kinetic parameters kcat, KM, and 
kcat/KM with tRNA
Gly
 and tRNA
Val 
are very similar (see Fig.8, Table 2).  This result reinforces 
the observation seen with Trm10 specific activity for tRNA
Gly
 and tRNA
Val 
(see Fig. 6 Table 1), 
and leads to the conclusion that tRNA sequence alone is not a determinant for Trm10 m
1
G9 
methyltransferase activity.  
 We note that these results also constitute the first measurements of steady-state kinetic 
parameters for Trm10 activity with tRNA substrates, which will also serve as an important 
foundation for the future analysis of Trm10 variant proteins produced during investigation of the 
second aim of this research project, described below. 
 Alanine-scanning mutagenesis to identify amino acids that are potentially important 
for the S. cerevisiae Trm10 catalytic mechanism. Identification of Trm10 residues that 
participate in the methyltransferase activity is important in order to understand the potentially 
novel catalytic mechanism of this enzyme family.  Moreover, identification of catalytic amino 
acid residues will be critical to understanding the relationship between Trm10 methyltransferase 
activity and the unusual 5-FU hypersensitivity of the deletion strain, as well as the participation 
of Trm10 in the unusual proteinaceous form of RNase P (see discussion).  In the absence of 
structural information or significant homology to other known enzyme families, the method of 
multiple sequence comparison was used to identify potential targets for investigation, on the 
basis that amino acids that participate in catalysis are also likely to be highly conserved between 
Trm10 family members.   
 To determine amino acid residues necessary for Trm10 methyltransferase activity, two 
different sequence alignments have been used. The first alignment included an exhaustive 
sampling of Trm10 homologs across eukaryotes, including all of the multiple Trm10 isoforms 
observed in higher eukaryotes, such as H. sapiens and M. musculus (Fig. 9).  Alanine-screens, 
based on this alignment, were used to probe among a candidate pool of 8 highly conserved 
residues.  The variant proteins were expressed and purified as described previously for wild-type 
Trm10.  The yields and purity of the final protein preparations were somewhat variable; the 
implications of this are discussed in more detail below.  For all of the variants, the specific 
activities with site-specifically labeled  tRNA
Gly
 and tRNA
Val 
 substrates were measured to 
characterize the alanine-variants activity relative to wild type Trm10 (Fig. 11 1
st
 8 residues).  
Results indicate that two residues, E111A and Q118A, are likely to participate in Trm10 
catalysis due to nearly 100 fold decreases in specific activity relative to wild type for both tRNA 
substrates, tRNA
Gly
 and tRNA
Val
.  Other interesting variants include K215A and R243A.  We 
note the potentially interesting roles of K215 and R243, which may play roles in tRNA substrate 
recognition, since these variants were ~10X fold less active than wild-type Trm10 with tRNA
Gly
, 
yet only ~2X less active than wild-type Trm10 with tRNA
Val 
(data not shown). 
 
However, given 
the variability in purity for each of the variant proteins, these assays are unable to distinguish 
between decreases in specific activity that result from overall decreased stability of the variant 
protein versus decreases that result from direct effects on catalytic activity due to amino acid 
variation. 
 Based on complementation experiments in yeast (data not shown and unpublished) and 
results that indicate an alternative biological role of at least one of the H. sapiens Trm10 
isoforms, a new alignment was produced that excludes some of the more distantly related Trm10 
homologs found in higher eukaryotes, on the basis that additional residues more relevant to m
1
G9 
formation would be revealed.  As might be expected in this case, several more highly conserved 
residues were apparent in the new alignment, and 12 of these additional amino acid residues 
were also investigated by mutagenesis to alanine, revealing 6 more residues that may be 
catalytically important in the Trm10 methyltransferase reaction; thus bringing the total to 10 
residues which may be catalytically relevant (Fig. 11).   Based on the second alignment, D100, 
N126, and W264 appear to be most affected by mutagenesis to alanine, while M107A, Y185A, 
and Y203A, show significant decreases in activity as well.  However, from this set of alanine 
variants, only N126A seems to be stable, the other 5 variants display significant structural 
instability.  Due to a significant amount of apparent structural instability (as revealed by 
increased susceptibility to proteolysis compared to the purified wild-type enzyme as well as 
increased amounts of precipitation of the purified protein during storage after purification) 
observed in 5 of these 8 alanine variants, the distinction between structurally important versus 
chemically important residues needs to be elucidated by further purification, or biophysical 
techniques.   
 
 
 
 
 
 
Discussion 
  S. cerevisiae Trm10 m
1
G9 methyltransferase activity has been investigated using two 
approaches: characterization of substrate specificity and determination of amino acid residues 
necessary for catalysis.  It has been shown that E. coli purified Trm10 catalyzes N-1 methylation 
at G9 for specific tRNAs; determined by sensitive quantification and comparison of Trm10 
methyltransferase (m
1
G9) activity with different site-specifically labeled tRNAs.  Determination 
of steady-state kinetic parameters for unmodified in vitro transcripts, tRNA
Gly
 and tRNA
Val
, 
shows simple nucleotide sequence is not the determining factor for Trm10 methyltransferase 
activity in vitro.  In vivo isolated tRNAs from trm10∆ yeast lack m1G9 containing tRNAs, an 
observation relevant to future projects in the lab.  Finally, at least 10 residues have been 
identified that could participate in Trm10 methyltransferase activity, however the distinction 
between direct catalytic importance versus structurally important amino acids residues remains 
unclear.  
On the topic of substrate specificity, the results from this study suggest that the 
mechanism by which Trm10 recognizes a specific subset of G9-containing tRNAs for 
modification is more complicated than might be expected, and similarly raises many new 
questions to be addressed in future studies.  Specifically, the observation that tRNA
Gly
 and 
tRNA
Val 
are both recognized as Trm10 substrates in vitro, yet the same tRNA
Val
 species is not 
modified in tRNA isolated from yeast suggests that additional mechanisms must exist to allow 
Trm10 to recognize substrate versus non-substrate tRNAs in vivo.  One possible explanation for 
this result may stem from the observation that the tRNA substrates for the in vitro assays are also 
created enzymatically in vitro by T7 RNA polymerase, and therefore lack the full complement of 
additional modifications present in in vivo produced tRNAs.  Therefore, it is possible that 
additional modifications are required for the tRNAs to be recognized according to their known in 
vivo specificities.  To test the hypothesis that other tRNA modifications may contribute to 
substrate specificity in vivo, bulk RNAs isolated with this method will be subjected to Trm10 
methyltransferase assay conditions and then probed for modification status using the primer 
extension assay described previously.   Similarly, it appears that Trm10 is able to discriminate 
against tRNA
Leu
 in vitro, but not tRNA
Val
, raising the possibility of multiple levels for substrate 
recognition, where some tRNAs (such as tRNA
Leu
) are not inherently accommodated for in the 
Trm10 active site, while others (such as tRNA
Val
) might be accommodated under certain 
conditions and yet rejected for modification at a different step.  Another possibility related to 
substrate specificity, may be that protein factors in vivo may act in complex with or 
independently from Trm10 to determine substrate recognition.  Investigation of other tRNA 
species in terms of their ability to be methylated by Trm10 in vitro, could provide clearer 
information regarding whether the types of substrate specification mechanisms mentioned are 
likely observed within yeast, or indeed, other organsisms.  
Based on genomic evidence many lower order eukaryotes, including S. cerevisiae, 
contain only one isoform of Trm10, however in higher order eukaryotes like H.sapiens there are 
at least 3 isoforms present (designated Methyltransferase domain-1 MTD1, MTD2, and MTD3).  
Although all three isoforms share a significant degree of sequence homology, phylogenetic 
analysis showed that MTD2 is the most homologous to yeast Trm10 (13).  The presence of 
multiple isoforms may be closely tied to the questions of substrate specificity that have been 
addressed by this research project.  Do all three isoforms act on the same subset of tRNAs?  For 
instance does one tRNA get modified by MTD1 and another tRNA get modified by a different 
isoform? Are they modified by combinations of isoforms? Are they localized differently in the 
cell to only operate on tRNAs from certain sub-cellular compartments? One way to examine 
substrate specificity in vivo is to use complementation experiments with Trm10 homologs from a 
variety of eukaryotes.  However, trm10 knockout yeast do not display an observable phenotype 
under normal physiological conditions (13).  Instead, the basis for a screen relies on the recent 
observation that many tRNA and rRNA modification enzymes are sensitive to 5-fluorouracil (5-
FU), with trm10∆ yeast being the most sensitive to 5-FU cytotoxicity, and moreover that 
sensitivity increased with higher growth temperatures (15).   
We have recently shown that the 5-FU hypersensitivity of trm10∆ yeast can be reverted 
when a wild-type copy of TRM10 operated under a Galactose-inducible promoter is transformed 
into yeast deletion strains and grown on YPD+Gal+5-FU (unpublished results).  Moreover, only 
the MTD2 isoform of human Trm10, which is most closely related to yeast Trm10, is capable of 
reverting the 5-FU hypersensitivity phenotype of the yeast deletion strain.  It is intriguing to 
postulate that this apparent difference in biological function of the multiple isoforms in metazoa 
may be related to differences in tRNA substrate specificity, and thus one could use a similar 
model to many of the experiments described in this work to examine the three H. sapiens Trm10 
isoforms with respect to their substrate specificity.   
The trm10∆ 5-FU phenotype observation also lays the groundwork for a different set of 
experiments that utilize the power of yeast genetics.  To examine the molecular basis for trm10∆ 
5-FU sensitivity, a trm10 mutant gene that encodes for an inactive variant of Trm10, for instance 
the Q118A variant from this study which is defective for m
1
G9 methyltransferase activity, can be 
transformed into the trm10Δ yeast strain to see if it can revert 5-FU sensitivity.  One could 
imagine that if the 5-FU phenotype were reverted, then methylation status at G9 is not the 
determinant for 5-FU sensitivity, and instead a different biological role for Trm10, separate from 
methyltransferase activity, is being affected by the presence of 5-FU.  The authors of the 5-FU 
hypersensitivity in trm10∆ yeast study hypothesized that the presence of m1G9 helps to stabilize 
specific tRNAs, and thus the observation that 5-FU hypersensitivity was exacerbated at higher 
temperatures provides evidence that tRNA stability is compromised by the lack of methylation at 
G9.  Given the scenario that the 5-FU hypersensitivity is not reverted by transformation of an 
inactive variant into trm10 knockout yeast, then one could isolate specific tRNAs known to 
contain m
1
G9 in vivo from wild type and trm10∆ yeast to produce melting profiles, where UV 
absorption would be plotted against temperature to determine if stability of tRNAs are being 
compromised due to absence of m
1
G9 modification.   
 In general the cellular locations, and indeed the subnuclear locations, where tRNAs are 
modified is an area of particular interest for researchers who study tRNA modifications (see 
review (17)). Moreover the cellular locations of certain modification enzymes may differ upon 
comparison from species to species. For instance a portion of Mod5p-II pool, part of the Mod5p 
family of enzymes responsible for i
6
A37 formation in yeast tRNAs, is present in the nucleolus 
(18), while in many budding yeast Mod5p-II is believed to be cytosolic (19). Another example of 
cytosolic tRNA modification enzymes includes S. cerevisiae Trm7p, responsible for nucleotide 
2’O-ribose methylation in the anticodon loop at nucleotides 32 and 34 (20).  Also in S. cerevisiae 
Pus1p, which catalyzes formation of Ψ from uridine, is found at the nuclear pore (21).  To the 
central point, this survey of tRNA modification enzymes, present in the nucleus, nucleolus, and 
cytosol, provides a general sampling of the diverse areas tRNA modifications are known to 
localize within the cell. 
 As of now there is no evidence for the precise location of S. cerevisiae Trm10, or where 
methyltransferase activity occurs, within the cell; however reconstitution of human 
mitochondrial RNaseP (mtRNaseP) holozenzyme identified one isoform of the H. sapiens Trm10 
homologs (MTD1) as a subunit along with two other proteins (16).  Unlike all other known 
RNaseP enzymes, except for spinach chloroplasts and trypanosome mitochondria, this form of 
human mitochondrial RNaseP is completely proteinaceous and thus does not require a trans-
acting RNA component to cleave 5’ leader sequences during premature mitochondrial, or in the 
case of spinach, premature chloroplast tRNA processing (16, 22-24). It should be noted that there 
is no evidence for Trm10 homologs present in yeast mitochondria, however this result may 
explain the biological importance of multiple isoforms in higher order eukaryotes.  This 
observation may also suggest something about where along the tRNA maturation pathway 
Trm10 m
1
G9 modification occurs, which in turn could also provide fundamental insight into 
substrate specificity.  
 In addition to substrate specificity this investigation has also sought to identify amino 
acid residues that may be necessary for catalysis.  We have identified at least 10 residues that 
could participate in Trm10 methyltransferase activity, 8 that are potentially catalytic and 2 
residues that may be involved in substrate specificity. Of the 8 amino acid residues that could be 
catalytic, five exhibit gross structural instability and need further study to determine if their 
catalytic importance is a result of effects on chemistry versus structure.  The relatively large 
number of Trm10 alanine variants that exhibit evidence of being structurally destabilized, such 
as increased susceptibility to proteolysis and precipitation, is unusual with respect to other 
tRNA-related enzymes that have been studied using an alanine-scanning approach (25, 26).   
 Three of the 8 residues, E111A, Q118A, and N126A, are structurally stable variants that 
clearly demonstrate chemical importance for Trm10 methyltransferase activity.  Although minor 
structural destabilization resultant from single-site alanine variation can certainly contribute to 
slight decreases in activity, it is unlikely to result in 100 fold decreases in activity relative to wild 
type Trm10 as observed with these variants.   Furthermore, two residues may be involved in 
substrate specifity, K215A and R243A, due to similar specific activities displayed by both 
variants with respect to wild type Trm10 using tRNA
Gly
 and tRNA
Val
 substrates.  
 While tRNA modification and processing raises interesting questions and merits future 
study, SAM-methyltransferases (SAM-MTs) as a superfamily of enzymes are not without their 
own inherent set of puzzling features; mysteries that can be highlighted using relevant 
observations with tRNA SAM-MTs.  There have been different attempts to characterize SAM-
MTs based on a variety of features including secondary structure conservation, domain binding 
motifs, chemical motifs, and/or amino acid structural motifs.  Interestingly, although different 
families of SAM-MTs share little in the way of identifiable sequence homology, common themes 
related to overall structural architecture have emerged that suggest distinct evolutionary paths to 
achieving similar catalytic activities within this family of enzymes.   The classic model of SAM-
MTs places the SAM binding domain at the N-terminus and substrate binding domain at the C-
terminus along a conserved secondary structure architecture of alternating α helices and β sheets 
(27).  Interesting families of tRNA SAM-MTs that may share potential features with Trm10, 
include Trm5 and TrmD, which have a related function to Trm10 in that they catalyze m
1
G 
formation, but each have been classified under two different classes of SAM-MT conserved fold 
motifs.  Close inspection of sequence comparisons between these families of enzymes may 
provide information related to potential functional or structural similarities at particular sites.  
However, based on the absence of overall sequence homology between Trm5, TrmD, and 
Trm10, this otherwise dissimilar family of tRNA SAM-MTs, may suggest, that Trm10 may is 
representative of even a third class of tRNA SAM-MTs.  
Methods   
Expression and purification of yeast Trm10.  E. coli cells were grown in LB+Amp liquid 
media at 37°C for over-expression of His6 tagged Trm10, lysed using a French-press and 
proteins in the resulting soluble crude extract were purified using immobilized metal ion affinity 
chromatography (IMAC) column directed to the N-terminal His6 tag in each protein.  Fractions 
of eluted sample were collected from the IMAC column and qualitatively assessed, by visual 
inspection, for protein content using Bio-rad® protein dye.  Fractions that contained the highest 
protein concentrations were collected and dialyzed into buffer containing 50% glycerol to further 
concentrate the purified protein samples.  SDS-PAGE analysis was used to assess the purity of 
protein obtained from the column and overall stability of Trm10 purified.  Trm10 alanine 
variants (created as described below) were all expressed and purified in the same way. 
 Preparation of tRNA substrates.  Three different E. coli strains, each with Amp
r
 
plasmids that encode for a specific tRNA (either tRNA
Gly
, tRNA
Val
, or tRNA
Leu
) and an upstream 
T7 RNA polymerase promoter were grown in LB media containing 100 µg/ml Ampicillin, and 
plasmid DNA was isolated from each culture using commercially available DNA purification 
kits (Qiagen).  The three tRNA encoding plasmids contained BstNI restriction enzyme cleavage 
sites downstream of the T7 RNA polymerase promoter, which allowed linearization of the 
isolated plasmid DNA for run-off tRNA transcription with T7 RNA polymerase (purified from a 
His6-tagged clone available in the lab).  In the transcription reactions, α
32
P labeled GTP was 
added to unlabeled GTP in the nucleotide triphosphate (NTP) mix, which results in the 
transcription of tRNAs that contain 
32
P labeled guanosines along the entire body of the tRNA 
wherever a guanosine occurs.  The resulting labeled transcripts were purified by denaturing 
polyacrylamide gel electrophoresis for use in enzymatic assays. 
 To obtain site-specific, internally labeled tRNA in vitro transcripts, plasmids encoding 
deletions of nucleotides 1-8 in tRNA
Gly
, tRNA
Val
, and tRNA
Leu
 were created by site-directed 
mutagenesis and used to transcribe 5' truncated tRNAs.  Transcription reactions were the same as 
described above, except using all unlabeled NTPs, which results in truncated tRNA transcripts 
that contain G9 at the 5’ terminus. Gel-purified, truncated transcripts were treated with CIP to 
remove the three 5’ phosphates left after transcription and then 5' labeled using T4 
polynucleotide kinase and γ32P ATP.  The purified, labeled RNA was ligated to a synthetic RNA 
oligonucleotide (Dharmacon) that recapitulates the 8 missing nucleotides in a DNA-splinted 
ligation reaction using T4 DNA ligase (28).  DNA oligo splints complementary to the 5’ end of 
truncated, labeled tRNAs and the synthetic RNA oligo were used to anneal the RNA strands for 
T4 DNA ligase activity.   
 Correct ligation of site-specifically labeled tRNA products was verified by digestion with 
T2 and P1 nucleases (see Fig. 13). The expected nucleotide products, U8p* (T2) and p*G9 (P1), 
were identified based on co-migration with unlabeled 5' monophosphorylated nucleotide 
standards using two different TLC solvent systems (Fig. 13B).  Nuclease T2 digested tRNAs 
resolved in the 0.5M NaFormate TLC solvent system enable accurate quantification of ligation 
efficiencies based on the ratio of U8p* to p*G9p, since these two labeled nucleotides migrate 
independently from one another, as well as other partially digested T2 tRNA products.   
Fig.XXXX shows ligation efficiencies with respect to Gly, Val, and Leu tRNAs. 
 In vitro methyltransferase activity assay.  For all labeled tRNAs tested, purified Trm10 
was added in the indicated amounts to reactions containing ~5000 cpm 
32
P labeled tRNAs, 0.5 
mM SAM,  50 mM tris pH 8.0, 2.5 mM MgCl2, 1 mM DTT, 50 mM NH4OAc, 1mM spermidine, 
and reactions were incubated at 30°C.  Addition of phenol was used to stop the reactions at 
desired times (2 hours for specific activity determination, or at timepoints designed to measure 
initial rates of product formation in steady-state kinetic assays) and each tRNA product was 
digested with Nuclease P1 to yield 5’ monophosphorylated nucleotides (NMP).  Importantly, 
Nuclease P1 treatment results in 5’ monophosphorylated guanosines and  5’ 
monophosphorylated N-1 methyl guanosines, if Trm10 methyltransferase activity has occurred. 
Thin layer chromatography on cellulose TLC plates was used to resolve the two nucleotide 
species due to the difference in migration between guanosine and m
1
-guanosine nucleotides (see 
Fig. 6) in an isobutyric acid:NH4OH:H2O (66:33:1) solvent system. To visualize the labeled 
m
1
G9 and G9 nucleotides phosphorimaging was used to quantify the amount of radioactivity 
derived from product and substrate, respectively.   
 Determination of G9 methylation in vivo using primer extension assay.  Low 
molecular weight RNAs were harvested from wild type and trm10∆ yeast using a hot phenol 
extraction.  Bulk RNA preps were treated with a 
32 
P labelled DNA primer complementary to the 
D arm of specific tRNAs, and primer extension with RT was used to assay modification status at 
nucleotide G9. 
Site-directed mutagenesis to create Trm10 alanine variants. To create single-site 
Trm10 alanine variants a Quikchange® mutagenesis kit was used, using sense and antisense 
DNA primers complementary to the Trm10 expression plasmid that encode the genetic sequence 
necessary to change an amino acid X codon, into an alanine encoding codon.  PCR-based 
techniques were used to amplify product plasmids, parent plasmids were digested with BstNI, 
and PCR product plasmids were transformed into E. coli (Xl-1 Blue).  Plasmids were isolated 
from single colonies, grown on LB+Amp, and sequenced to confirm X amino acid codon 
mutation to alanine.  Plasmids positive for alanine variation were transformed into 
Bl21(DE3)pLysS and Trm10 alanine variants were expressed and purified as described above.  
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